SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-074748
Filing Date
2017-03-08
Accepted
2017-03-08 16:16:02
Documents
3
Period of Report
2017-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d355080d8k.htm 8-K 15263
2 EX-99.1 d355080dex991.htm EX-99.1 57893
3 GRAPHIC g355080snap1.jpg GRAPHIC 8570
  Complete submission text file 0001193125-17-074748.txt   86242
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35837 | Film No.: 17675272
SIC: 2834 Pharmaceutical Preparations